RE

About

Psychedelics will have a significant global impact by introducing novel and effective treatments for depression, addiction, PTSD, anxiety and other mental health disorders. Receptor invests in this new biotech ecosystem through early and mid stage drug discovery companies.

Investment Focus

Stages
series-a seed

Contact Information

ir••••@receptorfund.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Receptor

Search Investors